Economic constraints and prescribing patterns in New Zealand.

作者信息

Kellaway G S

机构信息

Department of Pharmacology and Clinical Pharmacology, University of Auckland School of Medicine, New Zealand.

出版信息

Pharmacoeconomics. 1992 Sep;2(3):189-97. doi: 10.2165/00019053-199202030-00002.

DOI:10.2165/00019053-199202030-00002

PMID:10147009

Abstract

摘要

相似文献

Economic constraints and prescribing patterns in New Zealand.

Pharmacoeconomics. 1992 Sep;2(3):189-97. doi: 10.2165/00019053-199202030-00002.

The influence of pharmacoeconomic factors on prescribing patterns in Ireland.

Pharmacoeconomics. 1992 Aug;2(2):99-106. doi: 10.2165/00019053-199202020-00003.

Prescribing and drug costs in the province of Ontario.

Int J Health Serv. 1992;22(3):471-87. doi: 10.2190/94N5-P2ML-CVP7-5WAG.

The pills that ate your profits.

Hosp Health Netw. 1998 Feb 5;72(3):18-22.

Formulary management as a tool to improve medication use and gain physician support.

Am J Health Syst Pharm. 2007 Mar 1;64(5):464-6. doi: 10.2146/ajhp060332.

Initiatives to control drug costs associated with an independent physician association.

Am J Health Syst Pharm. 2003 Feb 1;60(3):269-72. doi: 10.1093/ajhp/60.3.269.

Explaining variations in general practice prescribing costs per ASTRO-PU (age, sex, and temporary resident originated prescribing unit).

BMJ. 1996 Feb 24;312(7029):488-9. doi: 10.1136/bmj.312.7029.488.

A review of limited lists and formularies: are they cost-effective?

Pharmacoeconomics. 1992 Mar;1(3):191-202. doi: 10.2165/00019053-199201030-00006.

Experts' agency problems: evidence from the prescription drug market in Japan.

Rand J Econ. 2007 Autumn;38(3):844-62. doi: 10.1111/j.0741-6261.2007.00115.x.

A qualitative study of GPs' and PCO stakeholders' views on the importance and influence of cost on prescribing.

Soc Sci Med. 2005 Mar;60(6):1335-46. doi: 10.1016/j.socscimed.2004.07.013.

本文引用的文献

A review of limited lists and formularies: are they cost-effective?

Pharmacoeconomics. 1992 Mar;1(3):191-202. doi: 10.2165/00019053-199201030-00006.

Quality of life instruments in the evaluation of new drugs.

Pharmacoeconomics. 1992 Feb;1(2):84-94. doi: 10.2165/00019053-199201020-00004.

Prescribing by consensus: the Wellington Hospital Board preferred medicines list.

N Z Med J. 1988 Jan 27;101(838):8-10.

Recent trends in drug prescribing rates and costs in New Zealand.

N Z Med J. 1988 May 11;101(845):233-6.

Economic costs and benefits of treating mild hypertension: results from a cross-sectional model.

N Z Med J. 1988 Oct 12;101(855):623-5.

Prevention and control of hypertension in New Zealand: a reappraisal.

N Z Med J. 1988 Jul 27;101(850):480-3.

Is the pharmacological treatment of mild to moderate hypertension cost effective in stroke prevention?

N Z Med J. 1988 Apr 13;101(843):167-71.

Variability in antihypertensive drug therapy in general practice: results from a random national survey.

N Z Med J. 1989 Jun 28;102(870):307-9.

The Nelson general practice prescribing project. Part I: A pilot audit of the regional prescribing profile.

N Z Med J. 1990 Nov 28;103(902):558-60.

A cost effectiveness analysis of the treatment of end stage renal failure.

N Z Med J. 1990 Apr 25;103(888):171-4.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验